| Course | DHA 733 Contemporary Leadership Issues (DHA/733) |
|---|---|
| Week | 4 |
| Paper type | Health technology leadership paper |
| Length | about 1,152 words, 4 double-spaced pages plus title page and references |
| Format | APA 7 student paper |
| School | University of Phoenix |
| Program | DHA |
| Updated | September 2026 |
Free sample paper for DHA 733 Week 4
Promise, Proof and Bias: A Leader's Framework for Adopting Artificial Intelligence in Rural Hospitals
[Student Name]
University of Phoenix
DHA/733: Contemporary Leadership Issues
Week 4 Assignment
[Instructor Name]
[Date]
The health network, the vendor proposals, pilot results, costs and governance are composites written for a model paper; research findings come from the sources cited.
In the same week, two vendors approached the regional vice president. One offered an ambient artificial intelligence scribe that listens to clinic visits and drafts notes, promising to give physicians back an hour a day. The other offered a sepsis prediction alert for inpatients, promising earlier treatment and fewer deaths. Together they would cost about $650,000 a year. Rural clinicians were enthusiastic about the scribe and skeptical of another alert. The finance director noted that $650,000 would pay for six nurses. This paper develops a framework for deciding.
The Promise for Rural Hospitals
Artificial intelligence holds real promise for small hospitals. Documentation consumes hours of clinicians' days and contributes to burnout, a serious problem where every physician lost is hard to replace. Prediction tools could help small teams notice deterioration earlier, especially at night when one nurse may cover many patients. But rural hospitals also have fewer staff to evaluate, implement and monitor technology, and they cannot afford expensive mistakes. The region has two information technology analysts for four hospitals, no data scientist and a single clinical informatics physician who works part time. Any tool it adopts must be simple to monitor, or it will run unexamined.
Lesson One: Algorithms Can Carry Bias
The first lesson comes from population health. Obermeyer and colleagues studied a commercial algorithm widely used to identify patients for extra care management and showed that a Black patient and a White patient given the same score were not equally ill: the Black patient was, on average, much sicker. The cause lay in what the tool was built to forecast. It predicted future spending, and because the system spends less on Black patients with a given illness burden, it read lower spending as better health. When the team retrained it to predict illness directly, most of the gap disappeared (Obermeyer et al., 2019).
What Bias Means for the Region
About half of the region's patients are Black, and many have faced barriers to care that lower their recorded costs. Any tool that uses past spending or utilization to predict need could direct resources away from the patients with the greatest need. Leaders must ask what each tool predicts and whether that target is fair. The region's own care management program selected patients partly by past emergency visits and admissions, a measure that could miss sick patients who avoid the hospital because of cost or distance. The population health team will review that selection rule using the lesson from Obermeyer's study.
Lesson Two: Vendor Claims May Not Hold
The second lesson concerns performance. Wong and colleagues externally validated a widely implemented proprietary sepsis model among 27,697 patients with 38,455 hospitalizations at an academic health system and reported modest discrimination, an area under the curve of 0.63. Of 2,552 patients who developed sepsis, the model missed 1,709, or 67%, even though it raised alerts on 6,971 hospitalizations, about 18% of the total, a pattern that breeds alert fatigue (Wong et al., 2021). An alert that fires for one patient in five and misses two cases in three teaches clinicians to ignore it.
What This Means for the Sepsis Alert
The sepsis vendor offered performance figures from its own development data. Wong's findings show why independent, local validation is essential before any purchase. A rural hospital with a few sepsis cases a month cannot afford a tool that adds noise without catching cases. Nurses on the region's units already respond to dozens of alarms a shift, from infusion pumps, monitors and bed alarms, and another low-value alert would compete for the same attention. The existing sepsis screening protocol, used by nurses at each assessment, performs reasonably in the region's own quality reviews.
Lesson Three: Ambient Scribes in Practice
The documentation tool has more encouraging early experience from a real deployment. Tierney and colleagues described a large medical group's rapid rollout of ambient AI scribes, reporting that physicians who used the technology spent less time on documentation and found visits more focused on patients, while emphasizing that clinicians must review drafted notes and that the technology required training, monitoring and attention to patient consent (Tierney et al., 2024).
What This Means for the Scribe
The scribe addresses a real burden, the fourth aim of clinician well-being, and early experience is promising. But questions remain: how well it handles Spanish-speaking patients and regional accents, how often notes contain errors, how patients feel about being recorded and whether time saved is real in rural clinics.
A Leader's Framework for AI
The vice president proposed five questions for every AI proposal. First, evidence: is there independent validation in settings like ours? Second, equity: how does the tool perform for different patient groups, and what does it predict? Third, workflow: does it save clinicians time or add burden? Fourth, cost: how does it compare with alternatives, including hiring staff? Fifth, governance: who will monitor it, and what would make us stop? A proposal that cannot answer all five questions is not ready for purchase, however impressive the demonstration.
Governance
A new AI oversight committee, including physicians, nurses, information technology, compliance, an equity lead and a patient representative, will review proposals, approve pilots, review monitoring data and retire tools that do not perform.
Decision on the Sepsis Alert
The region declined to purchase the sepsis alert. It will instead ask the vendor for independent validation data and, if promising, run a silent pilot in which the model scores patients without alerting clinicians, so its accuracy can be measured locally before any alerts fire.
Consent and Privacy
Ambient tools record conversations, so patients must understand and agree. The region will explain the tool in plain language, in English and Spanish, allow patients to decline without affecting their care and ensure recordings are deleted after notes are finalized, as the contract will require.
Decision on the Scribe
The region approved a six-month pilot of the scribe with twenty clinicians, half physicians and half advanced practice clinicians, with a comparison group. The pilot will measure documentation time, after-hours work, note errors found on audit, patient satisfaction and consent rates, and performance for Spanish-speaking patients.
Monitoring After Launch
AI performance can drift as patients, practices and documentation change. Any adopted tool will have quarterly performance reviews, subgroup analyses and a named owner responsible for pausing it if problems arise. Contracts will give the region access to the data needed for these reviews and the right to end the agreement if performance falls below agreed levels, terms the contract standards adopted earlier already require for critical vendors.
Conclusion
Artificial intelligence offers rural hospitals relief from documentation and help noticing illness, but evidence shows that algorithms can carry bias and vendor claims can fail in practice. A framework built on evidence, equity, workflow, cost and governance allowed the region to pilot a promising scribe carefully and decline an unproven alert.
References
Obermeyer, Z., Powers, B., Vogeli, C., & Mullainathan, S. (2019). Dissecting racial bias in an algorithm used to manage the health of populations. Science, 366(6464), 447-453. https://doi.org/10.1126/science.aax2342
Tierney, A. A., Gayre, G., Hoberman, B., Mattern, B., Ballesca, M., Kipnis, P., Liu, V., & Lee, K. (2024). Ambient artificial intelligence scribes to alleviate the burden of clinical documentation. NEJM Catalyst Innovations in Care Delivery, 5(3). https://doi.org/10.1056/CAT.23.0404
Wong, A., Otles, E., Donnelly, J. P., Krumm, A., McCullough, J., DeTroyer-Cooley, O., Pestrue, J., Phillips, M., Konye, J., Penoza, C., Ghous, M., & Singh, K. (2021). External validation of a widely implemented proprietary sepsis prediction model in hospitalized patients. JAMA Internal Medicine, 181(8), 1065-1070. https://doi.org/10.1001/jamainternmed.2021.2626
What the DHA 733 Week 4 instructions ask
The fourth DHA 733 assignment commonly addresses technology and artificial intelligence. Students are generally asked to describe a technology or AI application relevant to their organization, evaluate evidence on its accuracy, effects and risks, including bias, privacy, workflow and cost, examine how leaders should govern adoption and propose a plan for evaluating, implementing and monitoring the technology. Some versions ask students to assess a specific vendor product. Rely on independent evidence if so. Strong papers look past vendor claims to independent validation, consider effects on different patient groups and on clinicians' work, plan for monitoring after launch and connect technology decisions to the organization's aims.
How this DHA 733 Week 4 example is built
Two vendor proposals arriving in the same week, an ambient documentation tool and an AI sepsis alert, open the paper. The promise of AI for rural hospitals is described. Evidence on algorithmic bias shows how a widely used risk algorithm disadvantaged Black patients. An external validation of a proprietary sepsis model shows how vendor performance claims can fail in practice. Experience with ambient scribes at a large medical group informs the documentation decision. A leader's framework for evaluating AI, based on evidence, equity, workflow, cost and governance, is proposed. Decisions on both proposals follow, with a silent pilot for the alert, a controlled pilot for the scribe and monitoring measures.
DHA 733 Week 4 grading rubric: where the points go
The technology week generally rewards critical evaluation of evidence, attention to bias and safety and a sound governance plan. Graders look for the technology described clearly, independent evidence on accuracy and outcomes reviewed, bias and equity effects analyzed, workflow and clinician effects considered, costs weighed, governance structures proposed and a plan for piloting and monitoring. Peer-reviewed validation studies and research on algorithmic bias strengthen the paper. Testing a tool locally before full adoption earns credit. Planning for ongoing monitoring also earns marks, as does asking how a tool performs for patients who speak languages other than English. The last points reward balanced prose and an APA reference list without errors. Papers that accept vendor claims at face value usually score lower.
DHA 733 Week 4 help: mistakes to avoid
Many DHA 733 Week 4 papers either celebrate AI or fear it. Evaluate it instead. Ask what problem the tool solves and what evidence shows it works, preferably from independent studies in settings like yours. Ask how it performs for different groups of patients, since tools trained on one population can fail or discriminate in another. Ask what it does to clinicians' work: does it save time or add alerts? Weigh the cost against alternatives, including hiring people. Then set up governance: a committee with clinical, technical, equity and patient voices, a local pilot with clear measures and monitoring after launch, because performance can drift as patients and practices change.
Related DHA 733 sample papers
Other DHA 733 week samples
- DHA 733 Week 1: Contemporary Leadership Issues
- DHA 733 Week 2: Emerging Leadership Theories
- DHA 733 Week 3: Workforce Challenges
- DHA 733 Week 5: Leadership for Equity and Trust
- DHA 733 Week 6: Leading Organizational Change
- DHA 733 Week 7: New Administrative Model Proposal
- DHA 733 Week 8: Integrative Seminar Paper
More DHA sample papers
- DHA 715 Week 4: Contractual Risk
- DHA 721 Week 4: Marginal Analysis of a Rural Service
- DHA 722 Week 4: Medicaid and State Policy
- DHA 731 Week 4: Using Surveillance Data
DHA 733 Week 4 questions, answered
What does DHA/733 Week 4 usually ask for?
The fourth leadership paper commonly addresses technology and artificial intelligence, evaluating evidence, bias, workflow and cost and designing governance for adoption.
Where can I find a free DHA 733 Week 4 sample paper?
This page holds a complete technology leadership sample, free to read, with notes on each judgment. Name the tool or system you are evaluating, and your opening draft is free.
Can health care algorithms be biased?
Yes. One widely used care-management tool rated Black patients as healthier than equally sick White patients, because it forecast spending, and less is spent on Black patients at the same level of illness.
How well do vendor sepsis prediction models perform?
When one widely used proprietary model was tested independently, its discrimination was modest, with an area under the curve of 0.63; it failed to flag two of every three sepsis cases yet sent alerts on nearly one patient in five.
How should hospitals govern AI tools?
Through a committee that reviews independent evidence, tests tools locally, examines effects on different patient groups and on clinicians, weighs costs and monitors performance after launch.
Write yours, or have the desk draft it
This paper is an original model document written by our desk, not a submitted student paper and not an official University of Phoenix document. Read it for the moves, then write your own to the instructions in your classroom. If you want one built to your exact prompt and rubric, the first custom sample is free and arrives in 24 to 48 hours.
Request this one custom, free · All DHA 733 week samples · All courses